Carlsmed Raises $10 Million to Commercialize aprevo Spinal Devices

Carlsmed aprevo Spinal Implants

Carlsmed closed a $10 million Series A financing to commercialize a digital + surgical planning solution and personalized aprevo™ implants for the correction of spinal deformity. 

This joins an oversubscribed $2.5 million seed round which closed earlier this year.

Carlsmed was granted FDA 510(k) clearance and Breakthrough...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us